{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T18:00:39Z","timestamp":1790532039448,"version":"4.1.0"},"reference-count":43,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2016,12,16]],"date-time":"2016-12-16T00:00:00Z","timestamp":1481846400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0168396","type":"journal-article","created":{"date-parts":[[2016,12,19]],"date-time":"2016-12-19T13:47:28Z","timestamp":1482155248000},"page":"e0168396","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":43,"title":["Liraglutide Reduces Both Atherosclerosis and Kidney Inflammation in Moderately Uremic LDLr-\/- Mice"],"prefix":"10.1371","volume":"11","author":[{"given":"Line S.","family":"Bisgaard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus H.","family":"Bosteen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisbeth N.","family":"Fink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte M.","family":"S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Rosendahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina K.","family":"Mogensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salka E.","family":"Rasmussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bidda","family":"Rolin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars B.","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2515-3022","authenticated-orcid":true,"given":"Tanja X.","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,12,16]]},"reference":[{"issue":"7","key":"ref1","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1681\/ASN.2005101085","article-title":"Chronic kidney disease and mortality risk: a systematic review","volume":"17","author":"M Tonelli","year":"2006","journal-title":"Journal of the American Society of Nephrology: JASN"},{"issue":"17","key":"ref2","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1161\/01.CIR.0000095676.90936.80","article-title":"Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention","volume":"108","author":"MJ Sarnak","year":"2003","journal-title":"Circulation"},{"key":"ref3","unstructured":"U.S. Renal Data System, USRDS 2013 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2013."},{"issue":"9811","key":"ref4","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0140-6736(11)60178-5","article-title":"Chronic kidney disease","volume":"379","author":"AS Levey","year":"2012","journal-title":"Lancet"},{"issue":"1","key":"ref5","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/kisup.2014.2","article-title":"Overview of the cellular and molecular basis of kidney fibrosis","volume":"4","author":"AA Eddy","year":"2014","journal-title":"Kidney Int Suppl (2011)"},{"issue":"4","key":"ref6","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nrneph.2014.14","article-title":"Potential approaches to reverse or repair renal fibrosis","volume":"10","author":"D Tampe","year":"2014","journal-title":"Nature reviews Nephrology"},{"issue":"6","key":"ref7","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1097\/01.ASN.0000128371.33195.7B","article-title":"Increased Expression of Adhesion Molecules in Uremic Atherosclerosis in Apolipoprotein-E-Deficient Mice","volume":"15","author":"S Bro","year":"2004","journal-title":"Journal of the American Society of Nephrology: JASN"},{"issue":"3","key":"ref8","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1093\/cvr\/cvt049","article-title":"Osteopontin deficiency dampens the pro-atherogenic effect of uraemia","volume":"98","author":"TX Pedersen","year":"2013","journal-title":"Cardiovasc Res"},{"issue":"1","key":"ref9","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1681\/ASN.2004060495","article-title":"Uremia accelerates both atherosclerosis and arterial calcification in apolipoprotein E knockout mice","volume":"16","author":"ZA Massy","year":"2005","journal-title":"Journal of the American Society of Nephrology: JASN"},{"issue":"3","key":"ref10","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.metabol.2011.07.004","article-title":"Ezetimibe alone or in combination with pitavastatin prevents kidney dysfunction in 5\/6 nephrectomized rats fed high-cholesterol","volume":"61","author":"Y Mori","year":"2012","journal-title":"Metabolism"},{"issue":"10","key":"ref11","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/nm.3313","article-title":"AKT2 is essential to maintain podocyte viability and function during chronic kidney disease","volume":"19","author":"G Canaud","year":"2013","journal-title":"Nature medicine"},{"issue":"9","key":"ref12","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1161\/ATVBAHA.107.147645","article-title":"Exacerbation of albuminuria and renal fibrosis in subtotal renal ablation model of adiponectin-knockout mice","volume":"27","author":"K Ohashi","year":"2007","journal-title":"Arteriosclerosis, thrombosis, and vascular biology"},{"issue":"1","key":"ref13","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1681\/ASN.2007111233","article-title":"Proteasomal processing of albumin by renal dendritic cells generates antigenic peptides","volume":"20","author":"D Macconi","year":"2009","journal-title":"Journal of the American Society of Nephrology: JASN"},{"issue":"1","key":"ref14","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1210\/jc.2011-1508","article-title":"Exenatide exerts a potent antiinflammatory effect","volume":"97","author":"A Chaudhuri","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"ref15","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1177\/1479164113481817","article-title":"The GLP-1 receptor agonist liraglutide inhibits progression of vascular disease via effects on atherogenesis, plaque stability and endothelial function in an ApoE(-\/-) mouse model","volume":"10","author":"T Gaspari","year":"2013","journal-title":"Diabetes & vascular disease research"},{"issue":"10","key":"ref16","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1007\/s00125-011-2241-2","article-title":"Native incretins prevent the development of atherosclerotic lesions in apolipoprotein E knockout mice","volume":"54","author":"M Nagashima","year":"2011","journal-title":"Diabetologia"},{"issue":"3","key":"ref17","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/bph.12490","article-title":"Exendin-4 decreases liver inflammation and atherosclerosis development simultaneously by reducing macrophage infiltration","volume":"171","author":"Y Wang","year":"2014","journal-title":"Br J Pharmacol"},{"issue":"10","key":"ref18","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1016\/j.metabol.2012.03.002","article-title":"GLP-1 analog liraglutide protects against oxidative stress and albuminuria in streptozotocin-induced diabetic rats via protein kinase A-mediated inhibition of renal NAD(P)H oxidases","volume":"61","author":"H Hendarto","year":"2012","journal-title":"Metabolism"},{"issue":"4","key":"ref19","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/s00125-010-2028-x","article-title":"Glucagon-like peptide-1 receptor agonist ameliorates renal injury through its anti-inflammatory action without lowering blood glucose level in a rat model of type 1 diabetes","volume":"54","author":"R Kodera","year":"2011","journal-title":"Diabetologia"},{"issue":"5","key":"ref20","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1046\/j.1523-1755.2003.00255.x","article-title":"Plasticity of kidney cells: role in kidney remodeling and scarring","volume":"64","author":"AM El-Nahas","year":"2003","journal-title":"Kidney international"},{"issue":"2","key":"ref21","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1681\/ASN.2010040356","article-title":"TGF-alpha mediates genetic susceptibility to chronic kidney disease","volume":"22","author":"D Laouari","year":"2011","journal-title":"Journal of the American Society of Nephrology: JASN"},{"issue":"3","key":"ref22","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/ki.1996.95","article-title":"Mechanisms involved in the pathogenesis of tubulointerstitial fibrosis in 5\/6-nephrectomized rats","volume":"49","author":"V Kliem","year":"1996","journal-title":"Kidney international"},{"key":"ref23","article-title":"Diet-induced obesity and kidney disease\u2014In search of a susceptible mouse model","author":"SE Wicks","year":"2015","journal-title":"Biochimie"},{"issue":"11","key":"ref24","doi-asserted-by":"crossref","first-page":"e0141109","DOI":"10.1371\/journal.pone.0141109","article-title":"High Fat High Cholesterol Diet (Western Diet) Aggravates Atherosclerosis, Hyperglycemia and Renal Failure in Nephrectomized LDL Receptor Knockout Mice: Role of Intestine Derived Lipopolysaccharide","volume":"10","author":"SS Ghosh","year":"2015","journal-title":"PloS one"},{"issue":"8","key":"ref25","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1093\/ndt\/gfq059","article-title":"The pro-inflammatory effect of uraemia overrules the anti-atherogenic potential of immunization with oxidized LDL in apoE-\/- mice","volume":"25","author":"TX Pedersen","year":"2010","journal-title":"Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association\u2014European Renal Association"},{"issue":"2","key":"ref26","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.atherosclerosis.2008.04.041","article-title":"Effect of treatment with human apolipoprotein A-I on atherosclerosis in uremic apolipoprotein-E deficient mice","volume":"202","author":"TX Pedersen","year":"2009","journal-title":"Atherosclerosis"},{"issue":"4","key":"ref27","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.2337\/db09-1694","article-title":"Inhibition of monocyte adhesion to endothelial cells and attenuation of atherosclerotic lesion by a glucagon-like peptide-1 receptor agonist, exendin-4","volume":"59","author":"M Arakawa","year":"2010","journal-title":"Diabetes"},{"issue":"2","key":"ref28","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1177\/1479164111404257","article-title":"A GLP-1 receptor agonist liraglutide inhibits endothelial cell dysfunction and vascular adhesion molecule expression in an ApoE-\/- mouse model","volume":"8","author":"T Gaspari","year":"2011","journal-title":"Diabetes & vascular disease research"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.peptides.2013.12.015","article-title":"A glucagon-like peptide-1 analog liraglutide suppresses macrophage foam cell formation and atherosclerosis","volume":"54","author":"Y Tashiro","year":"2014","journal-title":"Peptides"},{"issue":"6","key":"ref30","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/nm.3866","article-title":"KLF4-dependent phenotypic modulation of smooth muscle cells has a key role in atherosclerotic plaque pathogenesis","volume":"21","author":"LS Shankman","year":"2015","journal-title":"Nature medicine"},{"issue":"3","key":"ref31","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1161\/01.ATV.0000201060.47945.cb","article-title":"Uremia-specific effects in the arterial media during development of uremic atherosclerosis in apolipoprotein E-deficient mice","volume":"26","author":"S Bro","year":"2006","journal-title":"Arteriosclerosis, thrombosis, and vascular biology"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"784","DOI":"10.2741\/4337","article-title":"Chronic kidney disease alters vascular smooth muscle cell phenotype","volume":"20","author":"MA Monroy","year":"2015","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"3","key":"ref33","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.semnephrol.2010.03.003","article-title":"Macrophages and immunologic inflammation of the kidney","volume":"30","author":"JS Duffield","year":"2010","journal-title":"Semin Nephrol"},{"issue":"6","key":"ref34","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1111\/j.1523-1755.2004.66038.x","article-title":"CCR1 blockade reduces interstitial inflammation and fibrosis in mice with glomerulosclerosis and nephrotic syndrome","volume":"66","author":"V Vielhauer","year":"2004","journal-title":"Kidney international"},{"issue":"9","key":"ref35","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/ki.2011.249","article-title":"Macrophages are essential contributors to kidney injury in murine cryoglobulinemic membranoproliferative glomerulonephritis","volume":"80","author":"S Guo","year":"2011","journal-title":"Kidney international"},{"issue":"12","key":"ref36","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1681\/ASN.2005030297","article-title":"IL-10 suppresses chemokines, inflammation, and fibrosis in a model of chronic renal disease","volume":"16","author":"W Mu","year":"2005","journal-title":"Journal of the American Society of Nephrology: JASN"},{"issue":"5","key":"ref37","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1016\/S0002-9440(10)61209-6","article-title":"Conditional ablation of macrophages halts progression of crescentic glomerulonephritis","volume":"167","author":"JS Duffield","year":"2005","journal-title":"Am J Pathol"},{"issue":"4","key":"ref38","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/ki.2010.177","article-title":"Pivotal role of CD4+ T cells in renal fibrosis following ureteric obstruction","volume":"78","author":"TT Tapmeier","year":"2010","journal-title":"Kidney international"},{"key":"ref39","article-title":"CD103+ Dendritic Cells Elicit CD8+ T Cell Responses to Accelerate Kidney Injury in Adriamycin Nephropathy","author":"Q Cao","year":"2015","journal-title":"Journal of the American Society of Nephrology: JASN"},{"issue":"3","key":"ref40","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1046\/j.1523-1755.2001.059003975.x","article-title":"Depletion of CD4(+) T cells aggravates glomerular and interstitial injury in murine adriamycin nephropathy","volume":"59","author":"Y Wang","year":"2001","journal-title":"Kidney international"},{"issue":"5","key":"ref41","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.kint.2016.01.016","article-title":"The dipeptidyl peptidase inhibitor linagliptin and the angiotensin II receptor blocker telmisartan show renal benefit by different pathways in rats with 5\/6 nephrectomy","volume":"89","author":"O Tsuprykov","year":"2016","journal-title":"Kidney international"},{"issue":"4","key":"ref42","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1159\/000363300","article-title":"Recent advances in animal models of diabetic nephropathy","volume":"126","author":"B Betz","year":"2014","journal-title":"Nephron Exp Nephrol"},{"issue":"23","key":"ref43","doi-asserted-by":"crossref","first-page":"13330","DOI":"10.1073\/pnas.231476798","article-title":"Genetically increased angiotensin I-converting enzyme level and renal complications in the diabetic mouse","volume":"98","author":"W Huang","year":"2001","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0168396","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T23:43:09Z","timestamp":1540338189000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0168396"}},"subtitle":[],"editor":[{"given":"Jaap A.","family":"Joles","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,12,16]]},"references-count":43,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2016,12,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0168396","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,16]]}}}